[FATE] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
06-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -39.04%
YoY- -103.77%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 2,632 1,661 1,026 1,027 1,026 1,027 1,026 87.50%
PBT -19,760 -16,027 -16,782 -19,654 -14,135 -12,497 -10,684 50.72%
Tax 1,091 817 339 376 331 -131 378 102.84%
NP -19,760 -16,027 -16,782 -19,654 -14,135 -12,497 -10,684 50.72%
Tax Rate - - - - - - - -
Total Cost 22,392 17,688 17,808 20,681 15,161 13,524 11,710 54.12%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -750.76 -964.90 -1,635.67 -1,913.73 -1,377.68 -1,216.85 -1,041.33 -19.61%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.30 -0.25 -0.31 -0.37 -0.27 -0.29 -0.26 10.01%
EPS Diluted -0.30 -0.25 -0.31 -0.37 -0.27 -0.29 -0.26 10.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.